Syndromic inherited poikiloderma due to a de novo mutation in FAM111B by Takeichi, T. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1111/bjd.14845
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Takeichi, T., Nanda, A., Yang, H., Hsu, C., Lee, J., Al-ajmi, H., ... Mcgrath, J. (2016). Syndromic inherited
poikiloderma due to a de novo mutation in FAM111B. British Journal of Dermatology. DOI: 10.1111/bjd.14845
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/bjd.14845 
This article is protected by copyright. All rights reserved. 
Received Date : 26-Feb-2016 
Revised Date   : 11-May-2016 
Accepted Date : 12-Jun-2016 
Article type      : Research Letter 
 
 
 
BJD-2016-0399.R1      FINAL ACCEPTED VERSION 
 
Research Letter 
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Poikiloderma in neonates and infants often presents a diagnostic challenge, with the 
differential diagnosis including rare inherited disorders such as Rothmund-Thomson 
syndrome, Bloom syndrome, dyskeratosis congenita, Baller-Gerold syndrome, poikiloderma 
with neutropaenia, Weary syndrome and Kindler syndrome.1 Moreover, the differential 
diagnosis may also include subtypes of porphyria and xeroderma pigmentosum, as well as 
other rare metabolic, neoplastic, mitochondrial or premature ageing disorders, including 
Werner syndrome. Recently, a new form of poikiloderma has been described: hereditary 
fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis 
(POIKTMP).2 This is an autosomal dominant condition which was shown by whole exome 
sequencing (WES) to result from mutations in FAM111B (Homo sapiens family with 
sequence similarity 111, member B), encoding a trypsin-like cysteine/serine peptidase.2,3 
FAM111B has also been implicated in other pathology, including exocrine pancreatic 
dysfunction and susceptibility to prostate cancer.4,5 
The main clinicopathological features of POIKTMP comprise early-onset 
poikiloderma, ectodermal dysplasia anomalies, muscle contractures, myopathy, pulmonary 
fibrosis, growth retardation, liver impairment, exocrine pancreatic insufficiency, cataracts 
and haematological abnormalities.2,3  To date, 15 families with POIKTMP have been 
reported in which 5 different pathogenic missense mutations in FAM111B have been 
identified.2,3  Precisely how mutations in FAM111B lead to the main histological 
abnormalities of systemic adiposis and fibrosis, however, is uncertain. Here, we describe a 
new case of POIKTMP and extend the spectrum of clinical anomalies. 
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Our case is a 14 year old Kuwaiti girl. She is the youngest of 12 siblings born to 
related parents (2nd degree cousins), but with no family history for any similar disorder. She 
was born at full term after an uneventful pregnancy, with a birth weight of 3.0kg, and there 
were no immediate perinatal abnormalities. After a few days, however, she was noticed to 
have flushing on the cheeks with a recurrent papulovesicular facial eruption (Fig. 1a). 
Thereafter the clinical features (Fig. 1b-d) have comprised: height and weight below 5th 
percentile; progressive generalized poikiloderma since early infancy (accentuated in 
exposed sites); worsening non-scarring alopecia affecting scalp, eyebrows and eyelashes; 
recurrent gingivitis followed by poor dentition; persistent photosensitivity and heat 
intolerance; intermittent bony aches (limbs); sclerosis affecting the nose, fingers and toes; 
and hypothyroidism (on thyroxine replacement). Other normal or negative findings include: 
normal intelligence; no respiratory abnormalities; no muscle weakness or wasting; no 
tendon abnormalities or joint contractures. Investigations revealed hypocalcaemia (adjusted 
calcium 1.71mmol/L; normal 2.20-2.60), low vitamin D (36.8nmol/L; normal 75-250) and 
mildly impaired renal function (urea 9.5 mmol/L; normal 2.2-6.4: creatinine 108 mmol/l; 
normal 15-88). Normal or negative findings included: full blood count; anti-nuclear 
antibodies; complement; zinc; porphyrin screen; immunoglobulins; growth hormone; bone 
scans.  
Following informed consent, genomic DNA from the patient was used for WES 
analysis, using methodology described elsewhere.6 For disease inheritance, we searched for 
potentially damaging homozygous, compound heterozygous or heterozygous variants. 
Given the history of consanguinity, we initially focused on deleterious homozygous variants 
but found no mutation that might explain the phenotype. Neither did we identify potentially 
pathogenic mutations in specific genes such as RECQL4 (mutated in Rothmund-Thomson 
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syndrome) or other genes implicated in inherited poikiloderma. However, among the 
heterozygous variants was a de novo change in FAM111B, the gene recently implicated in 
POIKTMP.2,3 Indeed, the specific mutation present in our patient, c.1289A>C (p.Gln430Pro), 
is identical to one of the 5 previously reported pathogenic mutations.3 We confirmed its 
presence in genomic DNA by Sanger sequencing and demonstrated its absence in parental 
genomic DNA, consistent with a de novo dominant mutation (Figure 1e). 
The previous individual reported with the mutation p.Gln430Pro (French male) did 
not have the major clinical manifestations of POIKTMP seen in most of the other affected 
individuals. Notably, as in our Kuwaiti girl, he had no clinical symptoms of myopathy 
(pathology was only evident on magnetic resonance imaging in his case). With regard to 
genotype-phenotype correlation, codon 430 is the most upstream of the known mutation 
sites; it is located outside of the functional domain, the possibility being that mutations in 
codons 625, 627 and 628 are associated with an earlier onset of the disease and a more 
severe phenotype in terms of cutaneous, muscle and/or visceral involvement. Nevertheless, 
there were differences in our patient compared to the other p.Gln430Pro case with regard 
to the presence/absence of sclerosis, vesicles, lymphoedema and, most significantly, 
interstitial pulmonary fibrosis. Our case currently lacks pulmonary abnormalities which were 
the cause of premature death in the French subject (aged 40 years). Nevertheless, many of 
the clinicopathological features of POIKTMP may only begin to manifest in teenagers, and 
therefore the future clinical course of our patient is uncertain, although close monitoring of 
her lung function is planned. Indeed, the dermatological features across all cases of 
POIKTMP, including those with the same FAM111B pathology are somewhat variable, for 
example in terms of nail dystrophy, lymphoedema, cellulitis, eczema or ichthyosis-like skin 
changes, palmoplantar erythema or keratoderma, sclerosis of the digits, and blisters.2,3 In 
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summary, this report identifies a new case of POIKTMP to highlight the clinical 
manifestations of this recently described entity but also how further studies are needed to 
understand FAM111B function and particularly the mechanisms underlying tissue fibrosis. 
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Figure legends 
 
Figure 1. Clinical and molecular features of POIKTMP. (a) Aged 3 months, there are signs of 
some poikiloderma on both cheeks with a resolving papulovesicular eruption; (b) Aged 6 
years, generalised poikiloderma, alopecia and growth retardation are evident; (c) Aged 13 
years, facial poikiloderma with loss of scalp hair and eyebrows; (d) Aged 13 years, there is 
some sclerosis of the fingers in addition to acral poikiloderma; (e) Sanger sequencing reveals 
a de novo missense mutation, p.Gln430Pro, in FAM111B. 
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